These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 11205258)
21. Enhancement of the sensitivity of renal cell carcinoma cells to fas-mediated cytotoxicity and apoptosis by the selective cyclooxygenase-2 inhibitor JTE-522. Sato N; Mizutani Y; Li YN; Fujiwara J; Ishida H; Toiyama D; Abe K; Hayashi I; Nakanishi H; Kawauchi A; Miki T Urol Int; 2010; 84(3):362-8. PubMed ID: 20389170 [TBL] [Abstract][Full Text] [Related]
22. Synergistic cytotoxicity and apoptosis of JTE-522, a selective cyclooxygenase-2 inhibitor, and 5-fluorouracil against bladder cancer. Mizutani Y; Kamoi K; Ukimura O; Kawauchi A; Miki T J Urol; 2002 Dec; 168(6):2650-4. PubMed ID: 12442003 [TBL] [Abstract][Full Text] [Related]
23. Effects of etodolac, a selective cyclooxygenase-2 inhibitor, on the expression of E-cadherin-catenin complexes in gastrointestinal cell lines. Noda M; Tatsumi Y; Tomizawa M; Takama T; Mitsufuji S; Sugihara H; Kashima K; Hattori T J Gastroenterol; 2002; 37(11):896-904. PubMed ID: 12483244 [TBL] [Abstract][Full Text] [Related]
24. Cyclooxygenase-2 (COX-2)-dependent and -independent anticarcinogenic effects of celecoxib in human colon carcinoma cells. Maier TJ; Schilling K; Schmidt R; Geisslinger G; Grösch S Biochem Pharmacol; 2004 Apr; 67(8):1469-78. PubMed ID: 15041464 [TBL] [Abstract][Full Text] [Related]
25. A selective cyclooxygenase-2 inhibitor, NS-398, enhances the effect of radiation in vitro and in vivo preferentially on the cells that express cyclooxygenase-2. Pyo H; Choy H; Amorino GP; Kim JS; Cao Q; Hercules SK; DuBois RN Clin Cancer Res; 2001 Oct; 7(10):2998-3005. PubMed ID: 11595687 [TBL] [Abstract][Full Text] [Related]
26. NS-398 inhibits tumor growth and liver metastasis of colon cancer through induction of apoptosis and suppression of the plasminogen activation system in a mouse model. Nishikawa M; Stapleton PP; Freeman TA; Gaughan JP; Matsuda T; Daly JM J Am Coll Surg; 2004 Sep; 199(3):428-35. PubMed ID: 15325613 [TBL] [Abstract][Full Text] [Related]
27. A mechanistic study of cigarette smoke and cyclooxygenase-2 on proliferation of gastric cancer cells. Shin VY; Liu ES; Ye YN; Koo MW; Chu KM; Cho CH Toxicol Appl Pharmacol; 2004 Feb; 195(1):103-12. PubMed ID: 14962510 [TBL] [Abstract][Full Text] [Related]
28. Direct evidence for a role of cyclooxygenase 2-derived prostaglandin E2 in human head and neck xenograft tumors. Zweifel BS; Davis TW; Ornberg RL; Masferrer JL Cancer Res; 2002 Nov; 62(22):6706-11. PubMed ID: 12438270 [TBL] [Abstract][Full Text] [Related]
29. Modulation of apoptosis and Bcl-2 expression by prostaglandin E2 in human colon cancer cells. Sheng H; Shao J; Morrow JD; Beauchamp RD; DuBois RN Cancer Res; 1998 Jan; 58(2):362-6. PubMed ID: 9443418 [TBL] [Abstract][Full Text] [Related]
30. A selective cyclooxygenase-2 inhibitor, NS-398, inhibits cell growth by cell cycle arrest in a human malignant fibrous histiocytoma cell line. Yamashita H; Osaki M; Honjo S; Yoshida H; Teshima R; Ito H Anticancer Res; 2003; 23(6C):4671-6. PubMed ID: 14981912 [TBL] [Abstract][Full Text] [Related]
31. [Effects of selective cyclooxygenase-2 inhibitor NS-398 on 5-fluorouracil chemotherapy and progression of colon cells: an experimental study]. Zhang YC; Wang S; Zhang H; Ye YJ; Liang B; Cui ZR Zhonghua Yi Xue Za Zhi; 2004 Apr; 84(7):583-6. PubMed ID: 15144595 [TBL] [Abstract][Full Text] [Related]
32. Expression of cyclooxygenase-2 in uterine endometrial cancer and anti-tumor effects of a selective COX-2 inhibitor. Hasegawa K; Ohashi Y; Ishikawa K; Yasue A; Kato R; Achiwa Y; Nishio E; Udagawa Y Int J Oncol; 2005 May; 26(5):1419-28. PubMed ID: 15809736 [TBL] [Abstract][Full Text] [Related]
33. The role of cyclooxygenase enzymes in the growth of human gall bladder cancer cells. Grossman EM; Longo WE; Panesar N; Mazuski JE; Kaminski DL Carcinogenesis; 2000 Jul; 21(7):1403-9. PubMed ID: 10874020 [TBL] [Abstract][Full Text] [Related]
34. Lamin B, caspase-3 activity, and apoptosis induction by a combination of HMG-CoA reductase inhibitor and COX-2 inhibitors: a novel approach in developing effective chemopreventive regimens. Swamy MV; Cooma I; Reddy BS; Rao CV Int J Oncol; 2002 Apr; 20(4):753-9. PubMed ID: 11894121 [TBL] [Abstract][Full Text] [Related]
35. Combination of cyclooxygenase-2 inhibitors and oxaliplatin increases the growth inhibition and death in human colon cancer cells. Lin J; Hsiao PW; Chiu TH; Chao JI Biochem Pharmacol; 2005 Sep; 70(5):658-67. PubMed ID: 16004971 [TBL] [Abstract][Full Text] [Related]
36. The cyclooxygenase 2-selective inhibitor NS398 inhibits proliferation of oral carcinoma cell lines by mechanisms dependent and independent of reduced prostaglandin E2 synthesis. Minter HA; Eveson JW; Huntley S; Elder DJ; Hague A Clin Cancer Res; 2003 May; 9(5):1885-97. PubMed ID: 12738747 [TBL] [Abstract][Full Text] [Related]
37. Cyclooxygenase-2 stimulates production of amyloid beta-peptide in neuroblastoma x glioma hybrid NG108-15 cells. Kadoyama K; Takahashi Y; Higashida H; Tanabe T; Yoshimoto T Biochem Biophys Res Commun; 2001 Feb; 281(2):483-90. PubMed ID: 11181073 [TBL] [Abstract][Full Text] [Related]
38. Inhibitory effect of a selective cyclooxygenase-2 inhibitor on liver metastasis of colon cancer. Nagatsuka I; Yamada N; Shimizu S; Ohira M; Nishino H; Seki S; Hirakawa K Int J Cancer; 2002 Aug; 100(5):515-9. PubMed ID: 12124799 [TBL] [Abstract][Full Text] [Related]
39. Suppression of N-nitrosomethylbenzylamine (NMBA)-induced esophageal tumorigenesis in F344 rats by JTE-522, a selective COX-2 inhibitor. Li Z; Shimada Y; Kawabe A; Sato F; Maeda M; Komoto I; Hong T; Ding Y; Kaganoi J; Imamura M Carcinogenesis; 2001 Apr; 22(4):547-51. PubMed ID: 11285187 [TBL] [Abstract][Full Text] [Related]
40. Significant growth inhibition of human lung cancer cells both in vitro and in vivo by the combined use of a selective cyclooxygenase 2 inhibitor, JTE-522, and conventional anticancer agents. Hida T; Kozaki K; Ito H; Miyaishi O; Tatematsu Y; Suzuki T; Matsuo K; Sugiura T; Ogawa M; Takahashi T; Takahashi T Clin Cancer Res; 2002 Jul; 8(7):2443-7. PubMed ID: 12114451 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]